Insider Transactions Reported by 18 Insiders of Merus N.V.

Symbol
MRUS on Nasdaq
Industry
Pharmaceutical Preparations
Location
3584 Cm Utrecht, DE

Insiders trading volume in the past year

Merus N.V. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bvf Partners L P/Il 10%+ Owner $6.47M Oct 7, 2021
Sven Ante Lundberg President, CEO & PEO, Director $4.23M Dec 12, 2025
Gregory D. Perry Chief Financial Officer & PFO $1.45M Dec 12, 2025
Andrew Joe Svp, Cmo $1.45M May 7, 2024
Hui Liu EVP, CBO & Head of Merus US $1.45M May 7, 2024
Peter Silverman Coo & Gc $1.45M -$4.59M -76% Dec 12, 2025
A. Geuijen Cecile SVP & Chief Scientific Officer $744K Jan 31, 2022
John de Kruif SVP & Chief Technology Officer $744K Jan 31, 2022
Lex Bakker SVP, Chief Development Officer $744K Jan 31, 2022
Harry Shuman VP Controller, PAO $372K -$1.15M -75.6% Dec 12, 2025
Jason Haddock Director $239K Dec 12, 2025
Victor Sandor Director $120K Dec 12, 2025
Anand Mehra Director $120K Dec 12, 2025
Mark T. Iwicki Director $120K Dec 12, 2025
Maxine Gowen Director $120K Dec 12, 2025
Paolo Pucci Director $120K Dec 12, 2025
Len Kanavy Director $120K Dec 12, 2025
Fabian Zohren Chief Medical Officer Dec 12, 2025

Recent Insider Transactions by Companies or Individuals for Merus N.V.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.